Future trends in the treatment of non-alcoholic steatohepatitis
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference101 articles.
1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat. Rev. Gastroenterol. Hepatol.,2018
2. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation;Ibrahim;Gut,2018
3. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?;Blond;Diabetologia,2017
4. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases;Chalasani;Hepatology,2018
5. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease;European Association for the Study of the Liver (EASL);J. Hepatol.,2016
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease;Journal of the American Heart Association;2023-12-05
2. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH;Scientific Reports;2023-01-28
3. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2022-11
4. Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease;Frontiers in Pharmacology;2022-04-25
5. FXR: structures, biology, and drug development for NASH and fibrosis diseases;Acta Pharmacologica Sinica;2022-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3